213 related articles for article (PubMed ID: 33451095)
1. AhR and Cancer: From Gene Profiling to Targeted Therapy.
Paris A; Tardif N; Galibert MD; Corre S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451095
[TBL] [Abstract][Full Text] [Related]
2. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis.
Schlezinger JJ; Liu D; Farago M; Seldin DC; Belguise K; Sonenshein GE; Sherr DH
Biol Chem; 2006 Sep; 387(9):1175-87. PubMed ID: 16972784
[TBL] [Abstract][Full Text] [Related]
3. Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.
Rosenberger A; Muttray N; Hung RJ; Christiani DC; Caporaso NE; Liu G; Bojesen SE; Le Marchand L; Albanes D; Aldrich MC; Tardon A; Fernández-Tardón G; Rennert G; Field JK; Davies MPA; Liloglou T; Kiemeney LA; Lazarus P; Wendel B; Haugen A; Zienolddiny S; Lam S; Schabath MB; Andrew AS; Duell EJ; Arnold SM; Goodman GE; Chen C; Doherty JA; Taylor F; Cox A; Woll PJ; Risch A; Muley TR; Johansson M; Brennan P; Landi MT; Shete SS; Amos CI; Bickeböller H;
Eur J Med Res; 2022 Jan; 27(1):14. PubMed ID: 35101137
[TBL] [Abstract][Full Text] [Related]
4. Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
Kim DK; Lee CY; Han YJ; Park SY; Han H; Na K; Kim MH; Yang SM; Baek S; Kim Y; Hwang JY; Lee S; Kang SS; Hong MH; Lim SM; Lee JB; Kim JH; Cho BC; Pyo KH
Front Immunol; 2024; 15():1330228. PubMed ID: 38680496
[TBL] [Abstract][Full Text] [Related]
5. The modern human aryl hydrocarbon receptor is more active when ancestralized by genome editing.
Helmbrecht N; Lackner M; Maricic T; Pääbo S
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2402159121. PubMed ID: 38739836
[TBL] [Abstract][Full Text] [Related]
6. Tumour Microenvironment: Roles of the Aryl Hydrocarbon Receptor, O-GlcNAcylation, Acetyl-CoA and Melatonergic Pathway in Regulating Dynamic Metabolic Interactions across Cell Types-Tumour Microenvironment and Metabolism.
Anderson G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375613
[TBL] [Abstract][Full Text] [Related]
7. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the cartography of the cancer ecosystem.
Rabbie R; Lau D; White RM; Adams DJ
Genome Biol; 2021 Mar; 22(1):87. PubMed ID: 33761966
[No Abstract] [Full Text] [Related]
9. Translating the Science of Cancer Dormancy to the Clinic.
Aguirre-Ghiso JA
Cancer Res; 2021 Sep; 81(18):4673-4675. PubMed ID: 34429327
[TBL] [Abstract][Full Text] [Related]
10. The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions.
Gargaro M; Scalisi G; Manni G; Mondanelli G; Grohmann U; Fallarino F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451129
[TBL] [Abstract][Full Text] [Related]
11. Aryl Hydrocarbon Receptor Signaling Controls CD155 Expression on Macrophages and Mediates Tumor Immunosuppression.
McKay ZP; Brown MC; Gromeier M
J Immunol; 2021 Mar; 206(6):1385-1394. PubMed ID: 33504618
[TBL] [Abstract][Full Text] [Related]
12. Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in
Han H; Davidson LA; Hensel M; Yoon G; Landrock K; Allred C; Jayaraman A; Ivanov I; Safe SH; Chapkin RS
Mol Cancer Res; 2021 May; 19(5):771-783. PubMed ID: 33495399
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy.
Gargaro M; Manni G; Scalisi G; Puccetti P; Fallarino F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924971
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.
Vogel CFA; Lazennec G; Kado SY; Dahlem C; He Y; Castaneda A; Ishihara Y; Vogeley C; Rossi A; Haarmann-Stemmann T; Jugan J; Mori H; Borowsky AD; La Merrill MA; Sweeney C
Front Immunol; 2021; 12():625346. PubMed ID: 33763068
[TBL] [Abstract][Full Text] [Related]
15. AHR in the intestinal microenvironment: safeguarding barrier function.
Stockinger B; Shah K; Wincent E
Nat Rev Gastroenterol Hepatol; 2021 Aug; 18(8):559-570. PubMed ID: 33742166
[TBL] [Abstract][Full Text] [Related]
16. Plant Occurring Flavonoids as Modulators of the Aryl Hydrocarbon Receptor.
Goya-Jorge E; Jorge Rodríguez ME; Veitía MS; Giner RM
Molecules; 2021 Apr; 26(8):. PubMed ID: 33923487
[TBL] [Abstract][Full Text] [Related]
17. Non-Genomic AhR-Signaling Modulates the Immune Response in Endotoxin-Activated Macrophages After Activation by the Environmental Stressor BaP.
Großkopf H; Walter K; Karkossa I; von Bergen M; Schubert K
Front Immunol; 2021; 12():620270. PubMed ID: 33868237
[TBL] [Abstract][Full Text] [Related]
18. The Differential Selectivity of Aryl Hydrocarbon Receptor (AHR) Agonists towards AHR-Dependent Suppression of Mammosphere Formation and Gene Transcription in Human Breast Cancer Cells.
Saito N; Kanno Y; Yamashita N; Degawa M; Yoshinari K; Nemoto K
Biol Pharm Bull; 2021; 44(4):571-578. PubMed ID: 33790107
[TBL] [Abstract][Full Text] [Related]
19. AHR signaling pathway reshapes the metabolism of AML/MDS cells and potentially leads to cytarabine resistance.
Jia Y; Guo J; Zhao Y; Zhang Z; Shi L; Fang Y; Wu D; Wu L; Chang C
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):492-500. PubMed ID: 33709099
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
